• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Editorial Staff
    • Publication Ethics
    • Indexing and Abstracting
    • Related Links
    • FAQ
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Iranian Journal of Immunology
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 15 (2018)
Volume Volume 14 (2017)
Volume Volume 13 (2016)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 12 (2015)
Volume Volume 11 (2014)
Volume Volume 10 (2013)
Volume Volume 9 (2012)
Volume Volume 8 (2011)
Volume Volume 7 (2010)
Volume Volume 6 (2009)
Volume Volume 5 (2008)
Volume Volume 4 (2007)
Volume Volume 3 (2006)
Volume Volume 2 (2005)
Volume Volume 1 (2004)
Sobhan, M., Farshchian, M., Hoseinzadeh, A., Ghasemibasir, H., Solgi, G. (2016). Serum Levels of IL-10 and IL-22 Cytokines in Patients with Psoriasis. Iranian Journal of Immunology, 13(4), 317-323.
Mohammad Reza Sobhan; Mahmood Farshchian; Ali Hoseinzadeh; Hamid Reza Ghasemibasir; Ghasem Solgi. "Serum Levels of IL-10 and IL-22 Cytokines in Patients with Psoriasis". Iranian Journal of Immunology, 13, 4, 2016, 317-323.
Sobhan, M., Farshchian, M., Hoseinzadeh, A., Ghasemibasir, H., Solgi, G. (2016). 'Serum Levels of IL-10 and IL-22 Cytokines in Patients with Psoriasis', Iranian Journal of Immunology, 13(4), pp. 317-323.
Sobhan, M., Farshchian, M., Hoseinzadeh, A., Ghasemibasir, H., Solgi, G. Serum Levels of IL-10 and IL-22 Cytokines in Patients with Psoriasis. Iranian Journal of Immunology, 2016; 13(4): 317-323.

Serum Levels of IL-10 and IL-22 Cytokines in Patients with Psoriasis

Article 8, Volume 13, Issue 4, Autumn 2016, Page 317-323  XML PDF (135.87 K)
Document Type: Short Paper
Authors
Mohammad Reza Sobhan1; Mahmood Farshchian1; Ali Hoseinzadeh1; Hamid Reza Ghasemibasir1; Ghasem Solgi* 2
1Psoriasis Research Center, Department of Dermatology, Farshchian Hospital, Hamadan University of Medical Sciences, Hamadan, Iran
2Immunology Department, School of medicine, Hamadan University of Medical Sciences, Hamadan, Iran
Abstract
Background: As a chronic inflammatory condition, psoriasis results from an interaction
between genetic and immunologic factors in a predisposing environment. In spite of
compelling evidence for the role of T cells and cytokines in psoriasis, interleukin (IL)-
10 and IL-22 have not been sufficiently investigated. Objective: To assess the serum
levels of IL-10 and IL-22 in patients with psoriasis compared to healthy controls.
Methods: A total of 28 patients with psoriasis were compared with 28 age and sexmatched
healthy subjects. Psoriasis Area and Severity Index (PASI) criteria were used
to measure the severity of the disease. Serum levels of IL-10 and IL-22 were measured
in both groups and compared. Results: The mean serum level of IL-10 was 89.5±18.7 in
patients compared to 117.2±23.4 pg/ml in the controls (p=0.36). Also, serum level of
IL-22 was 284.1±49.7 in patients versus 425.4±82.8 pg/ml in control group (p=0.17).
There was a significant direct correlation between levels of IL-10 and IL-22 in patients
group (p=0.0005). The clinical severity of psoriasis was significantly correlated with
high levels of IL-22 (p<0.0001).Conclusions: The decreased levels of IL-10 in psoriatic
patients and direct correlation between higher levels of IL-22 and disease severity
support the clinical implication of both cytokines in psoriasis.
Keywords
IL-10; IL-22; Psoriasis
Statistics
Article View: 1,164
PDF Download: 1,866
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by sinaweb.